1931 Stock Overview
An investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
IVD Medical Holding Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.78 |
| 52 Week High | HK$2.89 |
| 52 Week Low | HK$0.62 |
| Beta | -0.090 |
| 11 Month Change | -16.82% |
| 3 Month Change | 161.76% |
| 1 Year Change | -1.66% |
| 33 Year Change | -44.55% |
| 5 Year Change | -42.21% |
| Change since IPO | -42.02% |
Recent News & Updates
IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up
Oct 14
Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings
Sep 27IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings
Aug 17Recent updates
IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up
Oct 14Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings
Sep 27IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings
Aug 17Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding
Jun 07These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely
May 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 25IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 03IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings
Mar 30IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year
Mar 20If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity
Mar 06IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Feb 08Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Oct 22IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher
Oct 01IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297
Aug 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 05IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556
Mar 22Returns At IVD Medical Holding (HKG:1931) Are On The Way Up
Feb 16Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?
Oct 16Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)
Sep 28IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet
May 16IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053
Apr 14IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 23IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Mar 16IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital
Jul 30These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well
May 04There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital
Apr 20IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year
Mar 05Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 15
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like
Jan 31A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Jan 16Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?
Jan 01How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?
Dec 17Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?
Dec 02IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.
Nov 19Shareholder Returns
| 1931 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 9.2% | -0.6% | 0.4% |
| 1Y | -1.7% | -23.3% | 12.0% |
Return vs Industry: 1931 exceeded the Hong Kong Healthcare industry which returned -23.3% over the past year.
Return vs Market: 1931 underperformed the Hong Kong Market which returned 12% over the past year.
Price Volatility
| 1931 volatility | |
|---|---|
| 1931 Average Weekly Movement | 15.2% |
| Healthcare Industry Average Movement | 8.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.9% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 1931's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1931's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 815 | Kuk Sing Ho | www.ivdholding.com |
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing.
IVD Medical Holding Limited Fundamentals Summary
| 1931 fundamental statistics | |
|---|---|
| Market cap | HK$2.89b |
| Earnings (TTM) | HK$279.93m |
| Revenue (TTM) | HK$3.29b |
10.3x
P/E Ratio0.9x
P/S RatioIs 1931 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1931 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.06b |
| Cost of Revenue | CN¥2.37b |
| Gross Profit | CN¥694.85m |
| Other Expenses | CN¥434.41m |
| Earnings | CN¥260.44m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 22.67% |
| Net Profit Margin | 8.50% |
| Debt/Equity Ratio | 23.3% |
How did 1931 perform over the long term?
See historical performance and comparison